$ALTO
Alto Ingredients, Inc. Stock $alto

$alto Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023019976 Filed on March 14, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$313.9M	$328.4M	$1.336B
YoY Change	1.87%	-14.8%	10.57%
Cost Of Revenue	$317.1M	$349.8M	$1.363B
YoY Change	4.52%	1.86%	19.57%
Gross Profit	-$3.164M	-$21.33M	-$27.55M
YoY Change	-166.29%	-150.64%	-140.64%
Gross Profit Margin	-1.01%	-6.49%	-2.06%
Selling, General & Admin	$7.882M	$7.551M	$31.58M
YoY Change	3.32%	-19.74%	8.2%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.055M	$5.973M	$25.10M
YoY Change	-1.29%	3.48%	7.74%
% of Gross Profit
Operating Expenses	$7.882M	$7.551M	$31.58M
YoY Change	3.32%	-19.74%	8.2%
Operating Profit	-$11.62M	-$28.88M	-$61.36M
YoY Change	306.86%	-188.3%	-258.97%
Interest Expense	-$1.565M	-$968.0K	-$1.827M
YoY Change	682.5%	324.56%	-49.07%
% of Operating Profit
Other Income/Expense, Net	$19.00K	$930.0K	$862.0K
YoY Change	-95.81%	64.02%	-28.64%
Pretax Income	-$13.17M	-$31.15M	-$39.67M
YoY Change	406.0%	-182.8%	-183.43%
Income Tax	$0.00	$1.925M	$1.925M
% Of Pretax Income
Net Earnings	-$13.17M	-$33.39M	-$41.60M
YoY Change	406.0%	-192.38%	-190.27%
Net Earnings / Revenue	-4.19%	-10.17%	-3.11%
Basic Earnings Per Share	-$0.18		-$0.60
Diluted Earnings Per Share	-$0.18	-$0.46	-$0.60
COMMON SHARES
Basic Shares Outstanding	75.14M shares	73.96M shares	71.94K shares
Diluted Shares Outstanding	73.82K shares		71.94K shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.17M	$36.46M	$36.46M
YoY Change	-41.49%	-27.97%	-27.97%
Cash & Equivalents	$21.17M	$36.46M	$36.46M
Short-Term Investments
Other Short-Term Assets	$5.217M	$9.340M	$27.38M
YoY Change	-90.26%	30.16%	-27.28%
Inventory	$67.15M	$66.63M	$66.63M
Prepaid Expenses
Receivables	$66.54M	$68.66M	$68.66M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$171.6M	$199.1M	$199.1M
YoY Change	-28.86%	-13.25%	-13.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$244.2M	$239.1M	$258.0M
YoY Change	3.42%	7.42%	9.34%
Goodwill	$5.970M	$5.970M
YoY Change
Intangibles	$8.940M	$9.087M
YoY Change		239.32%
Long-Term Investments
YoY Change
Other Assets	$6.172M	$6.137M	$6.137M
YoY Change	20.03%	19.28%	-21.55%
Total Long-Term Assets	$288.3M	$279.2M	$279.2M
YoY Change	12.33%	9.31%	9.31%
TOTAL ASSETS
Total Short-Term Assets	$171.6M	$199.1M	$199.1M
Total Long-Term Assets	$288.3M	$279.2M	$279.2M
Total Assets	$459.9M	$478.3M	$478.3M
YoY Change	-7.63%	-1.37%	-1.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.41M	$28.12M	$28.12M
YoY Change	12.21%	20.92%	20.92%
Accrued Expenses	$17.33M	$26.56M	$33.91M
YoY Change	-27.09%	24.64%	34.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$53.85M	$78.02M	$78.02M
YoY Change	-32.84%	12.09%	12.09%
LONG-TERM LIABILITIES
Long-Term Debt	$83.74M	$68.36M	$68.36M
YoY Change	55.99%	35.73%	35.73%
Other Long-Term Liabilities	$8.966M	$8.797M	$23.86M
YoY Change	-57.39%	-15.36%	20.65%
Total Long-Term Liabilities	$92.71M	$77.15M	$92.22M
YoY Change	24.07%	26.99%	31.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.85M	$78.02M	$78.02M
Total Long-Term Liabilities	$92.71M	$77.15M	$92.22M
Total Liabilities	$166.2M	$170.2M	$170.2M
YoY Change	7.31%	21.82%	21.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$748.1M	-$734.6M
YoY Change		6.2%
Common Stock	$76.00K	$75.00K
YoY Change	-98.48%	2.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$293.7M	$308.1M	$308.1M
YoY Change
Total Liabilities & Shareholders Equity	$459.9M	$478.3M	$478.3M
YoY Change	-7.63%	-1.37%	-1.37%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$13.17M	-$33.39M	-$41.60M
YoY Change	406.0%	-192.38%	-190.27%
Depreciation, Depletion And Amortization	$6.055M	$5.973M	$25.10M
YoY Change	-1.29%	3.48%	7.74%
Cash From Operating Activities	-$23.35M	$4.209M	$6.049M
YoY Change	-311.02%	-90.96%	-77.45%
INVESTING ACTIVITIES
Capital Expenditures	$9.602M	$12.51M	$37.74M
YoY Change	-511.4%	-401.91%	-330.37%
Acquisitions			$14.69M
YoY Change
Other Investing Activities	-$3.500M	$0.00	$81.00K
YoY Change	-76.12%	-100.0%	-99.81%
Cash From Investing Activities	-$13.10M	-$12.51M	-$37.66M
YoY Change	-22.88%	-163.01%	-238.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.325M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$13.36M	25.41M	$19.01M
YoY Change	253.16%	-162.21%	-147.54%
NET CHANGE
Cash From Operating Activities	-$23.35M	4.209M	$6.049M
Cash From Investing Activities	-$13.10M	-12.51M	-$37.66M
Cash From Financing Activities	$13.36M	25.41M	$19.01M
Net Change In Cash	-$23.09M	17.11M	-$12.60M
YoY Change	977.92%	-33.09%	-190.4%
FREE CASH FLOW
Cash From Operating Activities	-$23.35M	$4.209M	$6.049M
Capital Expenditures	$9.602M	$12.51M	$37.74M
Free Cash Flow	-$32.95M	-$8.302M	-$31.70M
YoY Change	-345.92%	-116.37%	-173.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-21467
CY2022	dei	Entity Registrant Name EntityRegistrantName	ALTO INGREDIENTS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-2170618
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 South Second Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Pekin
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	61554
CY2022	dei	City Area Code CityAreaCode	(916)
CY2022	dei	Local Phone Number LocalPhoneNumber	403-2123
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022	dei	Trading Symbol TradingSymbol	ALTO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	266.5	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75144522	shares
CY2022	dei	Auditor Firm AuditorFirmId	49
CY2022	dei	Auditor Name AuditorName	RSM US LLP
CY2022	dei	Auditor Location AuditorLocation	Rochester, Minnesota
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36456000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50612000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	13069000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11513000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	105000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	378000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	68655000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86888000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	66628000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	54373000	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	4973000	usd
CY2021Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	15839000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9340000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10301000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	199121000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	229526000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	239069000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	222550000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	18937000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13413000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	11641000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9087000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2678000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5970000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6137000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5145000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	40131000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	32877000	usd
CY2022Q4	us-gaap	Assets Assets	478321000	usd
CY2021Q4	us-gaap	Assets Assets	484953000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	28115000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	23251000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26556000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21307000	usd
CY2022Q4	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3849000	usd
CY2021Q4	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3909000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6732000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13582000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12765000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7553000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78017000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	69602000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68356000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50361000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15062000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9382000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8797000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10394000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	170232000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	139739000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75154495	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75154495	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72777694	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72777694	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	75000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	73000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1040834000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1037205000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1822000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-284000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-734643000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-691781000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	308089000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	345214000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	478321000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	484953000	usd
CY2022	us-gaap	Revenues Revenues	1335621000	usd
CY2021	us-gaap	Revenues Revenues	1207892000	usd
CY2020	us-gaap	Revenues Revenues	897023000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1363171000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1140108000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	844164000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-27550000	usd
CY2021	us-gaap	Gross Profit GrossProfit	67784000	usd
CY2020	us-gaap	Gross Profit GrossProfit	52859000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31579000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29185000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31980000	usd
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	11750000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2230000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4571000	usd
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1580000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3100000	usd
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24356000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-61359000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	40070000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	9853000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	22652000	usd
CY2021	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness	-9860000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1827000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3587000	usd
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-17943000	usd
CY2020	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-9959000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	862000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1208000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	750000	usd
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-39672000	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	227045000	usd
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	47551000	usd
CY2020	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-17299000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1925000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1469000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-41597000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	46082000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17282000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2166000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-41597000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	46082000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-15116000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1265000	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1265000	usd
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1268000	usd
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	600000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42862000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	44217000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16384000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71944	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71098	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58609	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71944	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72219	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58609	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-41597000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	46082000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17282000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2106000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-3594000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1508000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-39491000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	49676000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18790000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2166000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39491000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	49676000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16624000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2679000	usd
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-601000	usd
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	70533000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	126000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16440000	usd
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5296000	usd
CY2020	alto	Sale Of Interests In Pal SaleOfInterestsInPAL	-5099000	usd
CY2020	alto	Pension Plan Adjustment PensionPlanAdjustment	-1508000	usd
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1268000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17282000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	296235000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2883000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2777000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	462000	usd
CY2021	alto	Pension Plan Adjustment PensionPlanAdjustment	3594000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1265000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	46082000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	345214000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3333000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2291000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1000	usd
CY2022	alto	Shares Issued To Orion SharesIssuedToOrion	3913000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1325000	usd
CY2022	alto	Pension Plan Adjustment PensionPlanAdjustment	2106000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1265000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-41597000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	308089000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-41597000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	46082000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17282000	usd
CY2022	us-gaap	Depreciation Depreciation	25095000	usd
CY2021	us-gaap	Depreciation Depreciation	23292000	usd
CY2020	us-gaap	Depreciation Depreciation	30268000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3100000	usd
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24356000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9860000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	9959000	usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-2230000	usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	4571000	usd
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	1580000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	4612000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	-257000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	19263000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	21619000	usd
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	14780000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	177000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	778000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1394000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-230000	usd
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-230000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	17889000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3333000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2883000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2679000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-217000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	158000	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	245000	usd
CY2020	alto	Interest Expense Added To Senior Notes InterestExpenseAddedToSeniorNotes	133000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23967000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	43554000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-30571000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15479000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16448000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19090000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-7690000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-38989000	usd
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1507000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5128000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4216000	usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4751000	usd
CY2021	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	3483000	usd
CY2020	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-1012000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2305000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	9110000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20503000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13215000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-19763000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6049000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26821000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71681000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	14766000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14685000	usd
CY2021	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	24000000	usd
CY2021	alto	Proceeds From Sale Of Madera ProceedsFromSaleOfMadera	19500000	usd
CY2020	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	19896000	usd
CY2020	alto	Proceeds From Magic Valley Asset Sale ProceedsFromMagicValleyAssetSale	10000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37744000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16384000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6580000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37663000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27116000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	23316000	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	59100000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-32325000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-45826000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5171000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	350000000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1265000	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	2853000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1325000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	462000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	75829000	usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5500000	usd
CY2020	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	9860000	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	29964000	usd
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	71536000	usd
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	25533000	usd
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	40249000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19014000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-39999000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-66422000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12600000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13938000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28575000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62125000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48187000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19612000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49525000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62125000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48187000	usd
CY2022	alto	Cash And Cash Equivalents CashAndCashEquivalents	36456000	usd
CY2021	alto	Cash And Cash Equivalents CashAndCashEquivalents	50612000	usd
CY2020	alto	Cash And Cash Equivalents CashAndCashEquivalents	47667000	usd
CY2022	alto	Value Of Restricted Cash ValueOfRestrictedCash	13069000	usd
CY2021	alto	Value Of Restricted Cash ValueOfRestrictedCash	11513000	usd
CY2020	alto	Value Of Restricted Cash ValueOfRestrictedCash	520000	usd
CY2022	alto	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	49525000	usd
CY2021	alto	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	62125000	usd
CY2020	alto	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	48187000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2208000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3489000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	17469000	usd
CY2022	alto	Capitalized Interest CapitalizedInterest	720000	usd
CY2021	alto	Capitalized Interest CapitalizedInterest	628000	usd
CY2020	alto	Capitalized Interest CapitalizedInterest	224000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2262000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	448000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-641000	usd
CY2020	us-gaap	Stock Issued1 StockIssued1	1268000	usd
CY2022Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	1600000	usd
CY2022	alto	Preferred Stock Dividends Loss Numerator PreferredStockDividendsLossNumerator	1265000	usd
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-42862000	usd
CY2022	alto	Loss Available To Common Stockholders Shares Denominator LossAvailableToCommonStockholdersSharesDenominator	71944	shares
CY2022	us-gaap	Accounts Receivable Sale AccountsReceivableSale	55667000	usd
CY2021	us-gaap	Accounts Receivable Sale AccountsReceivableSale	63929000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	105000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	378000	usd
CY2022	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	217000	usd
CY2021	alto	Bad Debt Expense BadDebtExpense	158000	usd
CY2020	alto	Bad Debt Expense BadDebtExpense	245000	usd
CY2022	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	0.6
CY2021	alto	Net Income Loss Attributed To Alto Ingredients Inc Loss Numerator NetIncomeLossAttributedToAltoIngredientsIncLossNumerator	46082000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	54373000	usd
CY2021	alto	Preferred Stock Dividends Loss Numerator PreferredStockDividendsLossNumerator	1265000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i><span style="text-decoration:underline">Concentration Risks</span></i> – Credit risk represents the accounting loss that would be recognized at the reporting date if counterparties failed completely to perform as contracted. Concentrations of credit risk, whether on- or off-balance sheet, that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions described below. Financial instruments that subject the Company to credit risk consist of cash balances maintained in excess of federal depository insurance limits and accounts receivable which have no collateral or security. The Company has not experienced any significant losses in such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company sells specialty alcohols to consumer product companies and fuel-grade ethanol to gasoline refining and distribution companies. The Company sold to customers representing 10% or more of the Company’s total net sales, as follows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Years Ended December 31,</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company had accounts receivable due from these customers totaling $10,469,000 and $14,302,000, representing 15% and 16% of total accounts receivable, as of December 31, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company purchases corn, its largest cost component in producing alcohols, from its suppliers. The Company purchased corn from suppliers representing 10% or more of the Company’s total corn purchases, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Years Ended December 31,</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Supplier A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">14</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">16</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-188; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As of December 31, 2022, approximately 44% of the Company’s employees were covered by a collective bargaining agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i> </i></p>
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	4612000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	43484000	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	38640000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	47736000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	35509000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6396000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6909000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	11197000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10837000	usd
CY2022Q4	us-gaap	Other Inventory OtherInventory	1299000	usd
CY2021Q4	us-gaap	Other Inventory OtherInventory	1118000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	66628000	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022	us-gaap	Impaired Intangible Asset Description ImpairedIntangibleAssetDescription	The Company amortizes intangible assets with definite lives using the straight-line method over their established lives of 10-12 years.
CY2022	alto	Net Income Loss Attributed To Alto Ingredients Inc Loss Numerator NetIncomeLossAttributedToAltoIngredientsIncLossNumerator	-41597000	usd
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	177000	usd
CY2021Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	778000	usd
CY2020Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	1394000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium Current DebtInstrumentUnamortizedPremiumCurrent	5034000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Premium Current DebtInstrumentUnamortizedPremiumCurrent	40000	usd
CY2022	alto	Conserve Capital Percentage ConserveCapitalPercentage	0.50	pure
CY2020	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	600000	usd
CY2021	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	44217000	usd
CY2021	alto	Loss Available To Common Stockholders Shares Denominator LossAvailableToCommonStockholdersSharesDenominator	71098	shares
CY2021	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	-0.62
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1121	shares
CY2021	alto	Income Available To Common Stockholders Loss Numerator IncomeAvailableToCommonStockholdersLossNumerator	44217000	usd
CY2021	alto	Income Available To Common Stockholders Shares Denominator IncomeAvailableToCommonStockholdersSharesDenominator	72219	shares
CY2021	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0.61
CY2020	alto	Net Income Loss Attributed To Alto Ingredients Inc Loss Numerator NetIncomeLossAttributedToAltoIngredientsIncLossNumerator	-15116000	usd
CY2020	alto	Preferred Stock Dividends Loss Numerator PreferredStockDividendsLossNumerator	1268000	usd
CY2020	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-16384000	usd
CY2020	alto	Loss Available To Common Stockholders Shares Denominator LossAvailableToCommonStockholdersSharesDenominator	58609	shares
CY2020	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	0.28
CY2022	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	964000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	964000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	2463000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3188000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8900500	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5031000	shares
CY2022Q4	us-gaap	Cash Cash	22652000	usd
CY2022	alto	Loan Advance LoanAdvance	700000000	usd
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0495	pure
CY2022Q3	alto	Repurchase Of Common Stock RepurchaseOfCommonStock	50000000	usd
CY2022Q3	alto	Excess Amount Of Initial Purchase ExcessAmountOfInitialPurchase	10000000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	usd
CY2022	alto	Purchase Authorization Additional Lender Value PurchaseAuthorizationAdditionalLenderValue	5000000	usd
CY2022	alto	Purchase Additional Amount PurchaseAdditionalAmount	10000000	usd
CY2022	alto	Repurchased Aggregate Shares RepurchasedAggregateShares	351000	shares
CY2022	alto	Repurchased Aggregate Value RepurchasedAggregateValue	1325000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for credit losses, net realizable value of inventory, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes and the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i> </i></p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i><span style="text-decoration:underline">Reclassifications</span></i> – Certain prior year amounts have been reclassified to conform to the current presentation. Such reclassifications had no effect on the consolidated net income (loss), working capital or stockholders’ equity reported in the consolidated statements of operations and consolidated balance sheets.</p>
CY2022Q1	alto	Purchased Membership Interests PurchasedMembershipInterests	1	pure
CY2022Q1	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	14000000	usd
CY2022Q1	alto	Net Working Capital NetWorkingCapital	1300000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	14000000	usd
CY2022Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	9000000	usd
CY2022Q1	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	5000000	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	3500000	usd
CY2022	us-gaap	Loans And Leases Receivable Gain Loss On Sales Net LoansAndLeasesReceivableGainLossOnSalesNet	29200000	usd
CY2021	us-gaap	Loans And Leases Receivable Gain Loss On Sales Net LoansAndLeasesReceivableGainLossOnSalesNet	35700000	usd
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	1000000	usd
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	3600000	usd
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.025	pure
CY2022	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness		usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1336148000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1232265000	usd
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-42929000	usd
CY2021	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	45263000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.59
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.63
CY2022	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	72893	shares
CY2021	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	72047	shares
CY2022	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife	P12Y
CY2020Q3	alto	Business Combination Promissory Notes BusinessCombinationPromissoryNotes	900000	usd
CY2022	alto	Incentive Fee Payable Description IncentiveFeePayableDescription	Under the terms of the marketing agreements, within ten days after delivering alcohol to Kinergy, an amount is paid to Kinergy equal to (i) the estimated purchase price payable by the third-party purchaser of the alcohol, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated incentive fee payable to Kinergy, which equals 1% of the aggregate third-party purchase price, provided that the marketing fee shall not be less than $0.015 per gallon and not more than $0.0225 per gallon.
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	0.03
CY2020Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	0.03
CY2022	alto	Purchase Price Description PurchasePriceDescription	(a) 5% of the aggregate third-party purchase price for wet corn gluten feed, wet distillers grains, corn condensed distillers solubles and distillers grains with solubles, or (b) 1% of the aggregate third-party purchase price for corn gluten meal, dry corn gluten feed, dry distillers grains, corn germ and corn oil. Each marketing agreement had an initial term of one year and has successive one year renewal periods at the option of the production facility.
CY2022	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	3505000000	usd
CY2021	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	2871000000	usd
CY2020	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	2778000000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1363171000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1140108000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	844164000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	567000000	usd
CY2022	alto	Useful Life Years UsefulLifeYears	P10Y10M24D
CY2021	alto	Income From Loan Forgivenes IncomeFromLoanForgivenes	-0.055	pure
CY2020	alto	Fair Value Adjustment FairValueAdjustment	0.127	pure
CY2020	alto	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Noncontrolling Interest EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsNoncontrollingInterest	-0.034	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006	pure
CY2022Q4	us-gaap	Assets Assets	478321000	usd
CY2021Q4	us-gaap	Assets Assets	484953000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	438033000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	398272000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	198964000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	175722000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	239069000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	222550000	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	24528000	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	23292000	usd
CY2020	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	30268000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15624000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	567000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	15057000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2678000	usd
CY2021Q4	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	2678000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	5970000000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008	pure
CY2022Q4	alto	Operating Lease Liability Payments Due Next Twelve Months OperatingLeaseLiabilityPaymentsDueNextTwelveMonths	588000	usd
CY2022Q4	alto	Operating Lease Liability Payments Due Year Two OperatingLeaseLiabilityPaymentsDueYearTwo	588000	usd
CY2022Q4	alto	Operating Lease Liability Payments Due Year Three OperatingLeaseLiabilityPaymentsDueYearThree	588000	usd
CY2022Q4	alto	Operating Lease Liability Payments Due Year Four OperatingLeaseLiabilityPaymentsDueYearFour	588000	usd
CY2022Q4	alto	Operating Lease Liability Payments Due Year Five OperatingLeaseLiabilityPaymentsDueYearFive	588000	usd
CY2022Q4	alto	Operating Lease Liability Payments Due After Year Five OperatingLeaseLiabilityPaymentsDueAfterYearFive	3469000	usd
CY2022Q4	alto	Operating Lease Liability Payments Due OperatingLeaseLiabilityPaymentsDue	6409000	usd
CY2022	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	19263000	usd
CY2021	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	21619000	usd
CY2020	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	14780000	usd
CY2022	alto	Type Of Instrument Cash Collateral Balance TypeOfInstrumentCashCollateralBalance	Cash collateral balance
CY2022	alto	Assets Balance Sheet Location Restrictedcashs AssetsBalanceSheetLocationRestrictedcashs	Restricted cash
CY2022Q4	alto	Assets Fair Value Restrictedcash AssetsFairValueRestrictedcash	13069000	usd
CY2022	alto	Type Of Instrument Commoditys Contracts1 TypeOfInstrumentCommoditysContracts1	Commodity contracts
CY2022	alto	Assets Balance Sheet Location Derivatives Assets AssetsBalanceSheetLocationDerivativesAssets	Derivative instruments
CY2022Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	4973000	usd
CY2022	alto	Liabilities Balance Sheet Location Derivative Liabilities LiabilitiesBalanceSheetLocationDerivativeLiabilities	Derivative instruments
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	6732000	usd
CY2021	alto	Type Of Instrument Cash Collateral Balance TypeOfInstrumentCashCollateralBalance	Cash collateral balance
CY2021	alto	Assets Balance Sheet Location Restrictedcashs AssetsBalanceSheetLocationRestrictedcashs	Restricted cash
CY2021Q4	alto	Assets Fair Value Restrictedcash AssetsFairValueRestrictedcash	11513000	usd
CY2021	alto	Type Of Instrument Commoditys Contracts1 TypeOfInstrumentCommoditysContracts1	Commodity contracts
CY2021	alto	Assets Balance Sheet Location Derivatives Assets AssetsBalanceSheetLocationDerivativesAssets	Derivative instruments
CY2021Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	15839000	usd
CY2021	alto	Liabilities Balance Sheet Location Derivative Liabilities LiabilitiesBalanceSheetLocationDerivativeLiabilities	Derivative instruments
CY2021Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13582000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.05	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.03	pure
CY2022Q4	us-gaap	Notes Payable NotesPayable	78076000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	50401000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4686000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5034000	usd
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	40000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68356000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50361000	usd
CY2022Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	57900000	usd
CY2022Q4	alto	Senior Secured Credit Facility SeniorSecuredCreditFacility	125000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	100000000	usd
CY2022Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	25000000	usd
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1282051	shares
CY2022	alto	Founder Shares FounderShares	320513	shares
CY2022Q4	us-gaap	Payments To Fund Policy Loans PaymentsToFundPolicyLoans	60000000	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1282051	shares
CY2022Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	60000000	usd
CY2022	us-gaap	Proceeds From Loans ProceedsFromLoans	3912000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.10	pure
CY2022	alto	Specified Leverage Description SpecifiedLeverageDescription	The Company must prepay amounts outstanding under the Term Loan on a semi-annual basis beginning with the six-month period ending December 31, 2023 in an amount equal to a percentage of the Company’s excess cash flow based on a specified leverage ratio, as follows: (i) if the leverage ratio is greater than or equal to 3.0x, then the mandatory prepayment amount will equal 100% of the Company’s excess cash flow, (ii) if the leverage ratio is less than 3.0x and greater than or equal to 1.5x, then the mandatory prepayment amount will equal 50% of the Company’s excess cash flow and (iii) if the leverage ratio is less than 1.5x, then the mandatory prepayment amount will equal 25% of the Company’s excess cash flow.
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	19300000	usd
CY2021Q2	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	700000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3900000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6000000	usd
CY2022	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	9900000	usd
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020	alto	Income From Loan Forgiveness IncomeFromLoanForgiveness		usd
CY2021	us-gaap	Lease Cost LeaseCost	4738000	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	18076000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	60000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	78076000	usd
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2022	us-gaap	Lessee Finance Lease Lease Not Yet Commenced Description LesseeFinanceLeaseLeaseNotYetCommencedDescription	The Company’s leases have remaining lease terms of approximately 1 year to 53 years, which includes options to extend the lease when it is reasonably certain the Company will exercise those options. For the year ended December 31, 2022, the weighted-average remaining lease terms of equipment and land-related leases were 5.09 years and 16.75 years, respectively.
CY2022	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	Right of use operating lease assets, net
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	18937000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13413000	usd
CY2022	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	Current portion, operating leases
CY2022Q4	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3849000	usd
CY2021Q4	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3909000	usd
CY2022	us-gaap	Lessee Operating Lease Assumptions And Judgments Discount Rate Description LesseeOperatingLeaseAssumptionsAndJudgmentsDiscountRateDescription	Operating leases, net of current portion
CY2022Q4	alto	Operating Noncurrent OperatingNoncurrent	15062000	usd
CY2021Q4	alto	Operating Noncurrent OperatingNoncurrent	9382000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	5224000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	4500000	usd
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	5732000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	124000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	238000	usd
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	212000	usd
CY2022	us-gaap	Lease Cost LeaseCost	5348000	usd
CY2020	us-gaap	Lease Cost LeaseCost	5944000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax	290000	usd
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	200000	usd
CY2022	us-gaap	Multiemployer Plans Plan Benefits Description MultiemployerPlansPlanBenefitsDescription	The Retirement Plan’s current investment target allocations are 50% equities and 50% debt. The pension committee periodically reviews the actual asset allocation in light of these targets and rebalances investments as necessary.
CY2022Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	3907000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	4313000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	3907000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	4313000	usd
CY2022Q4	alto	Defined Benefit Plan Accumulated Other Comprehensive Income Other Minimum Pension Liability After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeOtherMinimumPensionLiabilityAfterTax	310000	usd
CY2021Q4	alto	Defined Benefit Plan Accumulated Other Comprehensive Income Other Minimum Pension Liability After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeOtherMinimumPensionLiabilityAfterTax	210000	usd
CY2022Q4	alto	Defined Benefit Plan Accumulated Other Comprehensive Income Other Minimum Pension Other Liability After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeOtherMinimumPensionOtherLiabilityAfterTax	3597000	usd
CY2021Q4	alto	Defined Benefit Plan Accumulated Other Comprehensive Income Other Minimum Pension Other Liability After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeOtherMinimumPensionOtherLiabilityAfterTax	4103000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax	656000	usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	alto	Discription Of Adjusting Rate For Assumed Health Care DiscriptionOfAdjustingRateForAssumedHealthCare	the cost and obligation for pre-Medicare postretirement medical benefits, a 7.50% annual rate of increase in the per capita cost of covered benefits (i.e., health care trend rate) was assumed for the Postretirement Plan in 2024, adjusted to a rate of 4.50% in 2033
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1925000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1469000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1925000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1469000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.058	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.057	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.339	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.188	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.094	pure
CY2022	alto	Stockbased Compensation StockbasedCompensation	0.031	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.016	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.004	pure
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	58131000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	46159000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	26043000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	28640000	usd
CY2022Q4	alto	Disallowed Interest DisallowedInterest	2395000	usd
CY2021Q4	alto	Disallowed Interest DisallowedInterest	1059000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	3742000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	3742000	usd
CY2022Q4	alto	Pension Liability PensionLiability	1354000	usd
CY2021Q4	alto	Pension Liability PensionLiability	2189000	usd
CY2022Q4	alto	Railcar Contracts RailcarContracts	786000	usd
CY2021Q4	alto	Railcar Contracts RailcarContracts	618000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	634000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	479000	usd
CY2022Q4	alto	Derivatives Derivatives	460000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	311000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	367000	usd
CY2022	alto	Intangibles Intangibles	89000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3208000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2646000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	97153000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	85899000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	87949000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	75584000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9204000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10315000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	9125000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8896000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	749000	usd
CY2021Q4	alto	Derivative Derivative	606000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	315000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	300000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9440000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10551000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	236000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	236000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.64
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	98000	shares
CY2022Q4	alto	Federal Net Operating Losses FederalNetOperatingLosses	108100000	usd
CY2022	alto	Federal Taxable Income Utilize FederalTaxableIncomeUtilize	130058000	usd
CY2022	alto	Capital Loss Description CapitalLossDescription	Federal capital loss of $100,487,000 may be carried forward for 5 years and will expire in 2025. State capital loss of $95,469,000 may be carried forward for 5 years for most of the states in which the Company files returns and will expire in 2025.
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12365000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10104000	usd
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1623000	usd
CY2022	alto	Increases Related To Prior Year Tax Positions IncreasesRelatedToPriorYearTaxPositions	739000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	739000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	739000	usd
CY2022Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Bad Debt Reserve For Tax Purposes Of Qualified Lender DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityBadDebtReserveForTaxPurposesOfQualifiedLender	739000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	74000	usd
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	23000	usd
CY2022Q4	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	0.03
CY2022	us-gaap	Legal Fees LegalFees	25000	usd
CY2019Q4	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	5500000	shares
CY2019Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1
CY2019	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	977000	usd
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1
CY2020Q4	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	5075000	shares
CY2020Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	8.42
CY2020Q4	us-gaap	Shares Issued SharesIssued	3825493	shares
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.42
CY2022	alto	Gross Proceeds From Prefunded Warrants GrossProceedsFromPrefundedWarrants	75000000	usd
CY2022	alto	Net Offering Procdees NetOfferingProcdees	70500000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.77
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1387000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.3
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	872000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.21
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5500000	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2019Q4	alto	Weighted Average Exercises Price Warrants Outstanding WeightedAverageExercisesPriceWarrantsOutstanding	1
CY2020	alto	Warrants Exercised Number Of Shares WarrantsExercisedNumberOfShares	5500000	shares
CY2020	alto	Warrants Exercised Price Per Share WarrantsExercisedPricePerShare	1
CY2020	alto	Warrants Exercised Weighted Average Exercise Price WarrantsExercisedWeightedAverageExercisePrice	1
CY2020	alto	Prefunded Warrants Issued Number Of Sharesin Dollars Per Share PrefundedWarrantsIssuedNumberOfSharesinDollarsPerShare	3825000	shares
CY2020	alto	Prefunded Warrants Issued Price Per Share PrefundedWarrantsIssuedPricePerShare	0
CY2020	alto	Prefunded Warrants Issued Weighted Average Exercise Price PrefundedWarrantsIssuedWeightedAverageExercisePrice	0
CY2020	alto	Prefunded Warrants Exercised Number Of Shares PrefundedWarrantsExercisedNumberOfShares	3825000	shares
CY2020	alto	Prefunded Warrants Exercised Price Per Share PrefundedWarrantsExercisedPricePerShare	0
CY2020	alto	Prefunded Warrants Exercised Weighted Average Exercise Price PrefundedWarrantsExercisedWeightedAverageExercisePrice	0
CY2020	alto	Series A Warrants Issued Number Of Sharesin Dollars Per Share SeriesAWarrantsIssuedNumberOfSharesinDollarsPerShare	8900000	shares
CY2020	alto	Series A Warrants Issued Price Per Share SeriesAWarrantsIssuedPricePerShare	9.76
CY2020	alto	Series A Warrants Issued Weighted Average Exercise Price SeriesAWarrantsIssuedWeightedAverageExercisePrice	9.76
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8900000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.76
CY2020Q4	alto	Weighted Average Exercises Price Warrants Outstanding WeightedAverageExercisesPriceWarrantsOutstanding	9.76
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8900000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.76
CY2021Q4	alto	Weighted Average Exercises Price Warrants Outstanding WeightedAverageExercisesPriceWarrantsOutstanding	9.76
CY2022	alto	Warrants Expired Number Of Shares WarrantsExpiredNumberOfShares	8900000	shares
CY2022	alto	Warrants Expired Price Per Share WarrantsExpiredPricePerShare	9.76
CY2022	alto	Warrants Expired Weighted Average Exercise Price WarrantsExpiredWeightedAverageExercisePrice	9.76
CY2022Q4	alto	Issued Nonvoting Common Shares Exercisable IssuedNonvotingCommonSharesExercisable	3539236	shares
CY2020	alto	Stock Issued During Period Shares New Issues3 StockIssuedDuringPeriodSharesNewIssues3	1421000	shares
CY2019	alto	Stock Issued During Period Shares New Issues3 StockIssuedDuringPeriodSharesNewIssues3	3137000	shares
CY2020Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	5296000	shares
CY2019Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	3670000	shares
CY2020	us-gaap	Payments For Brokerage Fees PaymentsForBrokerageFees	171000	usd
CY2019	us-gaap	Payments For Brokerage Fees PaymentsForBrokerageFees	66000	usd
CY2022	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	1715000	shares
CY2016Q2	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	1150000	shares
CY2018Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	3650000	shares
CY2019Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	5650000	shares
CY2020Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	7400000	shares
CY2022Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	8900000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1051000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.66
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	39000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	6.23
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1169000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.95
CY2022Q4	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	6900000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	74000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.74
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.16
CY2021	alto	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised	124000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.74
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	9000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.9
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	74000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.74
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	74000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.74
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	74000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.74
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	74000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.74
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue	3.74
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	74000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y5M15D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.74
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	74000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.74
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	-63000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	79000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	262000	usd
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2260000	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.34
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	750000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.76
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1525000	shares
CY2021Q4	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	8810000	usd
CY2020Q4	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	1639000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3333000	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2883000	usd
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2679000	usd
CY2022	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	4863000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P0Y6M18D
CY2022Q4	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	15902000	usd
CY2022	alto	Indexedprice Purchase Contracts IndexedpricePurchaseContracts	142000	pure
CY2022	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	20986000	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	0	usd
CY2021Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	1000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.001
CY2022	alto	Other Warrants OtherWarrants	9.757
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	21661000	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	36826000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	alto	Stockbased Compensation StockbasedCompensation		pure
CY2021	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	alto	Interest Expense Added To Senior Notes InterestExpenseAddedToSeniorNotes		usd
CY2021	alto	Interest Expense Added To Senior Notes InterestExpenseAddedToSeniorNotes		usd
CY2022	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale		usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable		usd
CY2020	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment		usd
CY2020	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment		usd
CY2022	alto	Proceeds From Sale Of Madera ProceedsFromSaleOfMadera		usd
CY2020	alto	Proceeds From Sale Of Madera ProceedsFromSaleOfMadera		usd
CY2022	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets		usd
CY2021	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets		usd
CY2022	alto	Proceeds From Magic Valley Asset Sale ProceedsFromMagicValleyAssetSale		usd
CY2021	alto	Proceeds From Magic Valley Asset Sale ProceedsFromMagicValleyAssetSale		usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2020	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2022	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	alto	Income Loss Available To Common Stockholders Loss Numerator IncomeLossAvailableToCommonStockholdersLossNumerator	-42862000	usd
CY2022	alto	Loss Available To Common Stockholders Diluted LossAvailableToCommonStockholdersDiluted	71944	shares
CY2022	alto	Loss Available To Common Stockholder Diluted LossAvailableToCommonStockholderDiluted	-0.60
CY2021	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2020	alto	Income Loss Available To Common Stockholders Loss Numerator IncomeLossAvailableToCommonStockholdersLossNumerator	16384000	usd
CY2020	alto	Loss Available To Common Stockholders Diluted LossAvailableToCommonStockholdersDiluted	58609	shares
CY2020	alto	Loss Available To Common Stockholder Diluted LossAvailableToCommonStockholderDiluted	-0.28
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization		usd
CY2022	alto	Liabilities Balance Sheet Location LiabilitiesBalanceSheetLocation
CY2022Q4	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue		usd
CY2021	alto	Liabilities Balance Sheet Location LiabilitiesBalanceSheetLocation
CY2021Q4	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets		usd
CY2021Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets		usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2020	alto	Stockbased Compensation StockbasedCompensation		pure
CY2022	alto	Income From Loan Forgivenes IncomeFromLoanForgivenes		pure
CY2020	alto	Income From Loan Forgivenes IncomeFromLoanForgivenes		pure
CY2022	alto	Fair Value Adjustment FairValueAdjustment		pure
CY2021	alto	Fair Value Adjustment FairValueAdjustment		pure
CY2022	alto	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Noncontrolling Interest EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsNoncontrollingInterest		pure
CY2021	alto	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Noncontrolling Interest EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsNoncontrollingInterest		pure
CY2021Q4	alto	Derivatives Derivatives		usd
CY2021	alto	Intangibles Intangibles		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets		usd
CY2022Q4	alto	Derivative Derivative		usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022	alto	Increases Related To Current Year Tax Positions IncreasesRelatedToCurrentYearTaxPositions		usd
CY2021	alto	Increases Related To Current Year Tax Positions IncreasesRelatedToCurrentYearTaxPositions		usd
CY2022	alto	Decrease Related To Current Year Tax Positions DecreaseRelatedToCurrentYearTaxPositions		usd
CY2021	alto	Decrease Related To Current Year Tax Positions DecreaseRelatedToCurrentYearTaxPositions		usd
CY2021	alto	Increases Related To Prior Year Tax Positions IncreasesRelatedToPriorYearTaxPositions		usd
CY2022	alto	Decreases Related To Prior Year Tax Positions DecreasesRelatedToPriorYearTaxPositions		usd
CY2021	alto	Decreases Related To Prior Year Tax Positions DecreasesRelatedToPriorYearTaxPositions		usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2022Q4	alto	Weighted Average Exercises Price Warrants Outstanding WeightedAverageExercisesPriceWarrantsOutstanding
CY2022	alto	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000778164

Files In Submission

Name	View Source	Status
0001213900-23-019976-index-headers.html	Edgar Link	pending
0001213900-23-019976-index.html	Edgar Link	pending
0001213900-23-019976.txt	Edgar Link	pending
0001213900-23-019976-xbrl.zip	Edgar Link	pending
alto-20221231.xsd	Edgar Link	pending
f10k2022ex21-1_alto.htm	Edgar Link	pending
f10k2022ex23-1_alto.htm	Edgar Link	pending
f10k2022ex31-1_alto.htm	Edgar Link	pending
f10k2022ex31-2_alto.htm	Edgar Link	pending
f10k2022ex32-1_alto.htm	Edgar Link	pending
f10k2022_altoingred.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
alto-20221231_cal.xml	Edgar Link	unprocessable
alto-20221231_def.xml	Edgar Link	unprocessable
alto-20221231_lab.xml	Edgar Link	unprocessable
alto-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_altoingred_htm.xml	Edgar Link	completed
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALTO
Alto Ingredients, Inc. Stock $alto

2023 Q1 Form 10-K Financial Statement

#000121390023019976 Filed on March 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO Alto Ingredients, Inc. Stock $alto

2023 Q1 Form 10-K Financial Statement

#000121390023019976 Filed on March 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO
Alto Ingredients, Inc. Stock $alto